Royalty Pharma
RPRX
#635
Rank
HK$310.14 B
Marketcap
HK$539.39
Share price
2.18%
Change (1 day)
79.97%
Change (1 year)

Market capitalization of Royalty Pharma (RPRX)

Market cap: HK$310.14 Billion

As of November 2026 Royalty Pharma has a market cap of HK$310.14 Billion. This makes Royalty Pharma the world's 635th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.

Market cap history of Royalty Pharma from 2020 to 2026

End of year Market Cap

Year Marketcap Change
2026HK$310.14 B74.28%
2025HK$177.95 B52.33%
2024HK$116.82 B-11.19%
2023HK$131.53 B-3.42%
2022HK$136.20 B2.05%
2021HK$133.46 B-11.38%
2020HK$150.59 B

End of Day market cap according to different sources

On Nov 9th, 2026 the market cap of Royalty Pharma was reported to be:

HK$309.39 Billion
by Nasdaq info icon info icon
HK$310.14 Billion
by CompaniesMarketCap info icon info icon

Market capitalization for similar companies or competitors

Name Marketcap Market cap differencediff. Country
Abbott Laboratories
ABT
HK$1.501 T 384.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
HK$9.864 T 3,080.63%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
HK$12.08 B-96.10%๐Ÿ‡บ๐Ÿ‡ธ USA